CRVL
CorVel Corporation
CRVL's fundamentals are mixed: revenue grew 8.3%, while its operating margin rose 1 points to 16%. At 36x earnings, it's trading below its usual 47x.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CRVL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
CRVL's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CRVL.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CRVL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 32x | $76.95 | -11% |
| Current | 36x | $86.50 | — |
| Fair | 47x | $111 | +29% |
| Expensive | 59x | $141 | +63% |
Historical ranges are pointers, not guarantees.
CRVL's PE is in its cheap range at 36x.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CRVL Forward outlook
There aren't enough analyst estimates for CRVL to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CRVL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.38 | +18% |
| Q2 2026 | $2.25 | +17% |
| Q1 2026 | $2.14 | +17% |
| Q4 2025 | $2.03 | +19% |
| Q3 2025 | $2.02 | +29% |
| Q2 2025 | $1.93 | +29% |
| Q1 2025 | $1.83 | +24% |
| Q4 2024 | $1.70 | +18% |
CRVL has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CRVL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.1M | +11% |
| Q2 2026 | $259.9M | +11% |
| Q1 2026 | $248.5M | +7.4% |
| Q4 2025 | $235.6M | +3.4% |
| Q3 2025 | $239.6M | +6.8% |
| Q2 2025 | $234.7M | +11% |
| Q1 2025 | $231.5M | +12% |
| Q4 2024 | $228M | +13% |
CRVL's revenue has grown year over year for 22 quarters in a row: $267M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.2 points |
| Q2 2026 | 17% | +1.6 points |
| Q1 2026 | 16% | +1.6 points |
| Q4 2025 | 14% | +0.2 points |
| Q3 2025 | 15% | +2.2 points |
| Q2 2025 | 15% | +1.8 points |
| Q1 2025 | 14% | +3.5 points |
| Q4 2024 | 14% | +2.5 points |
CRVL has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CRVL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $29.3M | +92% |
| Q2 2026 | $43.1M | +8.9% |
| Q1 2026 | $20.3M | +42% |
| Q4 2025 | $35.2M | +9.5% |
| Q3 2025 | $15.3M | +23% |
| Q2 2025 | $39.5M | +21% |
| Q1 2025 | $14.3M | +174% |
| Q4 2024 | $32.1M | +43% |
CRVL has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CRVL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -238K shares |
| 1 year | -2% | -1M shares |
| 3 years | -2.6% | -1.3M shares |
| 5 years | -7.3% | -4M shares |
| Available history | -8.8% | -4.9M shares |
CRVL has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $18.6M |
| Q2 2026 | $22M |
| Q1 2026 | $20.2M |
| Q4 2025 | $13.6M |
| Q3 2025 | $12.8M |
| Q2 2025 | $9.6M |
| Q1 2025 | $9M |
| Q4 2024 | $9.5M |
CRVL spent $74M buying back its own shares over the past year, up 82% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CRVL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
CRVL has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CRVL.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CRVL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 76.6 | Overbought |
| Stochastic | 85.6 | Overbought |
CRVL's weekly RSI is 77 (overbought) and its Stochastic is 86 (overbought).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CRVL PE vs Financial Services Sector
| Metric | CRVL | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 13x | 179% above |
| PE % | 24 | 63 | 39 pts below |
CRVL is trading at 36x earnings, a 179% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CRVL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.3 | 7.7% above |
| 20 week MA | $71.3 | 21% above |
| 50 week MA | $64.4 | 34% above |
| 100 week MA | $81.5 | 6.2% above |
| 200 week MA | $80.9 | 7% above |
CRVL has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CRVL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.8 | $34.7 | +21% |
| 2021 | $34.7 | $66.1 | +90% |
| 2022 | $66.1 | $48.0 | -27% |
| 2023 | $48.0 | $82.4 | +72% |
| 2024 | $82.4 | $113.7 | +38% |
| 2025 | $113.7 | $69.1 | -39% |
| 2026 YTD | $69.1 | $86.5 | +25% |
CRVL has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.